A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer

por Balko, Justin M, Black, Esther P
Publicado 2009

Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors

por Toral, Keller J., Wuenschel, Mark A., Black, Esther P.
Publicado 2021

A microRNA signature of response to erlotinib is descriptive of TGFβ behaviour in NSCLC

por Krentz Gober, Madeline, Collard, James P., Thompson, Katherine, Black, Esther P.
Publicado 2017

Immune Checkpoint Inhibition and the Prevalence of Autoimmune Disorders Among Patients With Lung and Renal Cancer

por El-Refai, Sherif M, Brown, Joshua D, Black, Esther P, Talbert, Jeffery C
Publicado 2017

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

por Balko, Justin M, Potti, Anil, Saunders, Christopher, Stromberg, Arnold, Haura, Eric B, Black, Esther P
Publicado 2006

Deregulation of a Network of mRNA and miRNA Genes Reveals That CK2 and MEK Inhibitors May Synergize to Induce Apoptosis KRAS-Active NSCLC

por Gober, Madeline Krentz, Flight, Robert M, Lambert, Joshua, Moseley, Hunter, Stromberg, Arnold, Black, Esther P
Publicado 2019